| The kinetics of binding of soluble ACE2 to recombinant RBD was assessed by biolayer interferometry (BLI). The affinity of the B.1.351 RBD to ACE2 was 19-fold higher when compared to the wildtype and 2.7-fold higher when compared to the alpha variant. | ✍ | 33730597 (Cell)
PMID | 33730597 Date of Publishing: 2021 Apr 29 | Title | Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera | Author(s) name | Zhou D, Dejnirattisai W et al. | Journal | Cell | Impact factor | 27.35 Citation count: 406 | Date of Entry | 2021 Nov 2 |
×
NLM format |
Zhou D, Dejnirattisai W, Supasa P, Liu C, Mentzer AJ, Ginn HM, Zhao Y, Duyvesteyn HME, Tuekprakhon A, Nutalai R, Wang B, Paesen GC, Lopez-Camacho C, Slon-Campos J, Hallis B, Coombes N, Bewley K, Charlton S, Walter TS, Skelly D, Lumley SF, Dold C, Levin R, Dong T, Pollard AJ, Knight JC, Crook D, Lambe T, Clutterbuck E, Bibi S, Flaxman A, Bittaye M, Belij-Rammerstorfer S, Gilbert S, James W, Carroll MW, Klenerman P, Barnes E, Dunachie SJ, Fry EE, Mongkolsapaya J, Ren J, Stuart DI, Screaton GR. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell. 2021 Apr 29;184(9):2348-2361.e6. PMID:33730597 |
|
| Structure analysis of SARS-CoV-2 N439K Receptor Binding Domain (RBD) in complex with hACE2 at 2.8 resolution showed strong non-covalent salt bridges. These bridges enhanced the binding for hACE2 in the N439K variant, as similar to the SARS-CoV N439R variant. Double mutants of N439K/R and K417V mutations show that salt bridge loss at RBD position 417 is compensated by the one at position 439. This results in hACE2 affinity similar to the wild type. | Methods used for study: X-ray structure, Surface plasmon resonance (SPR) ✍ | 33621484 (Cell)
PMID | 33621484 Date of Publishing: 2021 Jan 28 | Title | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | Author(s) name | Thomson EC, Rosen LE et al. | Journal | Cell | Impact factor | 27.35 Citation count: 259 | Date of Entry | 2021 Aug 6 |
×
NLM format |
Thomson EC, Rosen LE, Shepherd JG, Spreafico R, da Silva Filipe A, Wojcechowskyj JA, Davis C, Piccoli L, Pascall DJ, Dillen J, Lytras S, Czudnochowski N, Shah R, Meury M, Jesudason N, De Marco A, Li K, Bassi J, O'Toole A, Pinto D, Colquhoun RM, Culap K, Jackson B, Zatta F, Rambaut A, Jaconi S, Sreenu VB, Nix J, Zhang I, Jarrett RF, Glass WG, Beltramello M, Nomikou K, Pizzuto M, Tong L, Cameroni E, Croll TI, Johnson N, Di Iulio J, Wickenhagen A, Ceschi A, Harbison AM, Mair D, Ferrari P, Smollett K, Sallusto F, Carmichael S, Garzoni C, Nichols J, Galli M, Hughes J, Riva A, Ho A, Schiuma M, Semple MG, Openshaw PJM, Fadda E, Baillie JK, Chodera JD; ISARIC4C Investigators; COVID-19 Genomics UK (COG-UK) Consortium, Rihn SJ, Lycett SJ, Virgin HW, Telenti A, Corti D, Robertson DL, Snell G. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell. 2021 Mar 4;184(5):1171-1187.e20. PMID:33621484 |
|